Herbicidal compositions comprising of phenylpyrazoline and triazolinone compounds

1 . A synergistic herbicidal composition comprising:

a. pinoxaden;

b. carfentrazone-ethyl;

c. at least one herbicide compound selected from fenoxaprop-p-ethyl or isoproturon; and

d. one or more excipients.

2 . The composition as claimed in claim 1 , comprising:

a. pinoxaden in the range of 1 to 12.5% w/w;

b. carfentrazone-ethyl in the range of 1 to 5% w/w;

c. at least one herbicide compound selected from fenoxaprop-p-ethyl in the range from 5 to 20% w/w and isoproturon in the range from 40 to 60% w/w; and

d. one or more excipients.

3 . The composition as claimed in claim 2 , wherein the composition is selected from a group consisting of:

4.5% w/w of pinoxaden, 2% w/w of carfentrazone-ethyl, 10% w/w of fenoxaprop-p-ethyl and one or more excipients;

9% w/w of pinoxaden, 4% w/w of carfentrazone-ethyl, 20% w/w of fenoxaprop-p-ethyl and one or more excipients; and

4.5% w/w of pinoxaden, 2% w/w of carfentrazone-ethyl, 50% w/w of isoproturon and one or more excipients.

4 . The composition as claimed in claim 1 , wherein the composition is formulated as capsule suspension (CS), dispersible concentrate (DC), dustable powder (DP), powder for dry seed treatment (DS), emulsifiable concentrate (EC), emulsifiable granule (EG), emulsion water-in-oil (EO), emulsifiable powder (EP), emulsion for seed treatment (ES), emulsion oil-in-water (EW), flowable concentrate for seed treatment (FS), granules (GR), micro-emulsion (ME), oil-dispersion (OD), oil miscible flowable concentrate (OF), oil miscible liquid (OL), oil dispersible powder (OP), suspension concentrate (SC), suspension concentrate for direct application (SD), suspo-emulsion (SE), water soluble granule (SG), soluble concentrate (SL), spreading oil (SO), water soluble powder (SP), water soluble tablet (ST), ultra-low volume (ULV) suspension, tablet (TB), ultra-low volume (ULV) liquid, water dispersible granules (WG), wettable powder (WP), water dispersible powder for slurry seed treatment (WS), water dispersible tablet (WT), a mixed formulation of CS and SC (ZC) or a mixed formulation of CS and SE (ZE), a mixed formulation of CS and EW (ZW).

5 . The composition as claimed in claim 4 , wherein the composition is formulated as ME and WP.

6 . The composition as claimed in claim 1 , wherein the excipient is selected from the group consisting of:

dispersing agent present in an amount in the range from 1 to 10% w/w;

wetting agent present in an amount in the range from 1 to 10% w/w;

emulsifier present in an amount in the range from 5 to 15% w/w;

defoamer present in an amount in the range from 0.1 to 5% w/w;

safener present in an amount in the range from 1 to 5% w/w;

co-solvent present in an amount in the range from 5 to 10% w/w; and

at least one of solvent or filler present in an amount of quantity sufficient to make 100% w/w formulation.

7 . The composition as claimed in claim 6 , wherein:

the dispersing agent is selected from the group consisting of sodium salt of naphthalene sulphonate condensate, sulfonated aromatic polymer sodium salt, sodium polycarboxylate, ethanesulfonic acid, 2-[methyl[(9Z)-1-oxo-9-octadecenyl]amino]-sodium salt, sodium 2-(methyloleoylamino)ethane-1-sulphonate, amine salt of phosphate tristyryl phenol ethoxylated, acrylic copolymer, graft copolymer, salt of naphthalene sulphonate, naphthalene sulfonate formaldehyde condensate, phosphate ester, salt of polycarboxylate, alcohol block copolymer, ethoxylated polyarylphenol phosphate ester, or a combination thereof;

the wetting agent is selected from the group consisting of sodium lauryl sulphate, sodium alkyl naphthalene sulfonate blend, sodium alkylnaphthalenesulfonate, sodium isopropyl naphthalene sulfonate, sodium dioctylsulfosuccinate, ethoxylated polyarylphenol phosphate ester, dioctyl sulphosuccinate, non-ionic ethoxylate, or a combination thereof;

the emulsifier is selected from the group consisting of castor oil ethoxylate, calcium dodecylbenzene sulfonate, blend of anionic-nonionic emulsifiers, tristyryl phenol, polyalkylene oxide block copolymer, high molecular weight polymer polyethylene glycol (PEG)-10, polypropylene glycol (PPG)-5 cetyl phosphate, ethylene oxide (EO)-polyethylene oxide (PO) block copolymer, non-ionic ethoxylated emulsifier, or a combination thereof;

the defoamer is selected from the group consisting of silicon emulsion, dimethyl polysiloxane emulsion, polysiloxane emulsion, or a combination thereof;

the safener is selected from the group consisting of 4-(dichloroacetyl)-1-oxa-4-azaspiro (4.5) decane (AD67), benoxacor, cloquintocet-mexyl, cyometrinil, cyprosulfamide, dichlormid, fenchlorazole-ethyl, flurazole, fluxofenim, furilazole, isoxadifen-ethyl, mefenpyr-diethyl, or a combination thereof;

the co-solvent is selected from the group consisting of 2-ethyl hexanol, n-butanol, dimethylsulfoxide (DMSO), N-methyl-2-pyrrolidone, cyclohexanone, or a combination thereof;

the solvent is selected from the group consisting of naphtha, xylene, decanamide, solvent C9, water, or a combination thereof; and

the filler is selected from the group consisting of silica and china clay, or a combination thereof.